Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Binding of HCN channels to GABAB receptors in dopamine neurons of the VTA limits synaptic inhibition and prevents the development of anxiety

E. Pérez-Garci, K. Pysanenko, G. Rizzi, F. Studer, D. Ulrich, T. Fritzius, S. Früh, A. Porcu, V. Besseyrias, A. Melichar, M. Gassmann, TR. Barkat, R. Tureček, KR. Tan, B. Bettler

. 2025 ; 206 (-) : 106831. [pub] 20250204

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25009647

During GABAergic synaptic transmission, G protein-coupled GABAB receptors (GBRs) activate K+ channels that prolong the duration of inhibitory postsynaptic potentials (IPSPs). We now show that KCTD16, an auxiliary GBR subunit, anchors hyperpolarization-activated cyclic nucleotide-gated (HCN) channels containing HCN2/HCN3 subunits to GBRs. In dopamine neurons of the VTA (DAVTA neurons), this interaction facilitates activation of HCN channels via hyperpolarization during IPSPs, counteracting the GBR-mediated late phase of these IPSPs. Consequently, disruption of the GBR/HCN complex in KCTD16-/- mice leads to prolonged optogenetic inhibition of DAVTA neuron firing. KCTD16-/- mice exhibit increased anxiety-like behavior in response to stress - a behavior replicated by CRISPR/Cas9-mediated KCTD16 ablation in DAVTA neurons or by intra-VTA infusion of an HCN antagonist in wild-type mice. Our findings support that the retention of HCN channels at GABAergic synapses by GBRs in DAVTA neurons provides a negative feedback mechanism that restricts IPSP duration and mitigates the development of anxiety.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009647
003      
CZ-PrNML
005      
20250429135002.0
007      
ta
008      
250415e20250204xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.nbd.2025.106831 $2 doi
035    __
$a (PubMed)39914775
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Pérez-Garci, Enrique $u Department of Biomedicine, Pharmazentrum, University of Basel, Klingelbergstrasse 50, CH-4056 Basel, Switzerland
245    10
$a Binding of HCN channels to GABAB receptors in dopamine neurons of the VTA limits synaptic inhibition and prevents the development of anxiety / $c E. Pérez-Garci, K. Pysanenko, G. Rizzi, F. Studer, D. Ulrich, T. Fritzius, S. Früh, A. Porcu, V. Besseyrias, A. Melichar, M. Gassmann, TR. Barkat, R. Tureček, KR. Tan, B. Bettler
520    9_
$a During GABAergic synaptic transmission, G protein-coupled GABAB receptors (GBRs) activate K+ channels that prolong the duration of inhibitory postsynaptic potentials (IPSPs). We now show that KCTD16, an auxiliary GBR subunit, anchors hyperpolarization-activated cyclic nucleotide-gated (HCN) channels containing HCN2/HCN3 subunits to GBRs. In dopamine neurons of the VTA (DAVTA neurons), this interaction facilitates activation of HCN channels via hyperpolarization during IPSPs, counteracting the GBR-mediated late phase of these IPSPs. Consequently, disruption of the GBR/HCN complex in KCTD16-/- mice leads to prolonged optogenetic inhibition of DAVTA neuron firing. KCTD16-/- mice exhibit increased anxiety-like behavior in response to stress - a behavior replicated by CRISPR/Cas9-mediated KCTD16 ablation in DAVTA neurons or by intra-VTA infusion of an HCN antagonist in wild-type mice. Our findings support that the retention of HCN channels at GABAergic synapses by GBRs in DAVTA neurons provides a negative feedback mechanism that restricts IPSP duration and mitigates the development of anxiety.
650    _2
$a zvířata $7 D000818
650    12
$a hyperpolarizační iontové kanály řízené cyklickými nukleotidy $x metabolismus $x genetika $7 D064428
650    12
$a receptory GABA-B $x metabolismus $7 D018080
650    _2
$a myši $7 D051379
650    12
$a dopaminergní neurony $x metabolismus $7 D059290
650    12
$a úzkost $x metabolismus $7 D001007
650    12
$a tegmentum mesencephali - area ventralis $x metabolismus $7 D017557
650    _2
$a myši knockoutované $7 D018345
650    _2
$a inhibiční postsynaptické potenciály $x fyziologie $x účinky léků $7 D053444
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši inbrední C57BL $7 D008810
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pysanenko, Kateryna $u Department of Auditory Neuroscience, Institute of Experimental Medicine, CAS, Videnska 1083, 14220 Prague 4, Czech Republic
700    1_
$a Rizzi, Giorgio $u Biozentrum, University of Basel, Spitalstrasse 41, CH-4056 Basel, Switzerland
700    1_
$a Studer, Florian $u Department of Biomedicine, Pharmazentrum, University of Basel, Klingelbergstrasse 50, CH-4056 Basel, Switzerland
700    1_
$a Ulrich, Daniel $u Department of Biomedicine, Pharmazentrum, University of Basel, Klingelbergstrasse 50, CH-4056 Basel, Switzerland
700    1_
$a Fritzius, Thorsten $u Department of Biomedicine, Pharmazentrum, University of Basel, Klingelbergstrasse 50, CH-4056 Basel, Switzerland
700    1_
$a Früh, Simon $u Department of Biomedicine, Pharmazentrum, University of Basel, Klingelbergstrasse 50, CH-4056 Basel, Switzerland
700    1_
$a Porcu, Alessandra $u Department of Biomedicine, Pharmazentrum, University of Basel, Klingelbergstrasse 50, CH-4056 Basel, Switzerland
700    1_
$a Besseyrias, Valérie $u Department of Biomedicine, Pharmazentrum, University of Basel, Klingelbergstrasse 50, CH-4056 Basel, Switzerland
700    1_
$a Melichar, Adolf $u Department of Auditory Neuroscience, Institute of Experimental Medicine, CAS, Videnska 1083, 14220 Prague 4, Czech Republic
700    1_
$a Gassmann, Martin $u Department of Biomedicine, Pharmazentrum, University of Basel, Klingelbergstrasse 50, CH-4056 Basel, Switzerland
700    1_
$a Barkat, Tania Rinaldi $u Department of Biomedicine, Pharmazentrum, University of Basel, Klingelbergstrasse 50, CH-4056 Basel, Switzerland
700    1_
$a Tureček, Rostislav $u Department of Auditory Neuroscience, Institute of Experimental Medicine, CAS, Videnska 1083, 14220 Prague 4, Czech Republic
700    1_
$a Tan, Kelly R $u Biozentrum, University of Basel, Spitalstrasse 41, CH-4056 Basel, Switzerland
700    1_
$a Bettler, Bernhard $u Department of Biomedicine, Pharmazentrum, University of Basel, Klingelbergstrasse 50, CH-4056 Basel, Switzerland. Electronic address: bernhard.bettler@unibas.ch
773    0_
$w MED00008403 $t Neurobiology of disease $x 1095-953X $g Roč. 206 (20250204), s. 106831
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39914775 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429134958 $b ABA008
999    __
$a ok $b bmc $g 2311177 $s 1246728
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 206 $c - $d 106831 $e 20250204 $i 1095-953X $m Neurobiology of disease $n Neurobiol Dis $x MED00008403
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...